Dallas, TX, United States of America

Joachim R Gruber


Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 39(Granted Patents)


Location History:

  • Gaithersburg, MD (US) (1998 - 2002)
  • Chestnut Hill, MA (US) (2000 - 2005)
  • Dallas, TX (US) (2002 - 2007)

Company Filing History:


Years Active: 1998-2007

Loading Chart...
9 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Joachim R. Gruber**

Introduction

Joachim R. Gruber is a prominent inventor based in Dallas, TX, recognized for his significant contributions to the field of biotechnology. With a portfolio of nine patents, his work primarily focuses on advancing medical treatments and promoting wound healing through groundbreaking discoveries in polynucleotides and polypeptides.

Latest Patents

Among Gruber's notable inventions is the patent for Keratinocyte growth factor-2 polynucleotides. This invention introduces newly identified polynucleotides and the polypeptides encoded by them, specifically targeting their therapeutic use in promoting or accelerating wound healing. The polypeptide, referred to as KGF-2 (previously known as Fibroblast Growth Factor 12), showcases novel mutant forms that exhibit enhanced activity, increased stability, higher yield, and improved solubility.

Another significant patent from Gruber is related to Fibroblast growth factor-13. This invention features a novel FGF-13 protein, a member of the fibroblast growth factor family. The patent provides isolated nucleic acid molecules encoding the human FGF-13 protein, along with methods for producing these proteins and screening for agonists and antagonists of FGF-13 activity. It also includes diagnostic and therapeutic methods for addressing FGF-13-related disorders.

Career Highlights

Gruber has made a substantial impact at Human Genome Sciences, Inc., where he has conducted pioneering research and development in the field of genomics and therapeutic proteins. His innovative approach and dedication to scientific advancements have contributed to the company's reputation as a leader in biotechnology.

Collaborations

In his career, Gruber has collaborated with esteemed colleagues such as Steven M. Ruben and Pablo Jimenez. Together, they have worked on various projects aimed at enhancing the understanding and application of growth factors in medical science, fostering a collaborative environment that promotes innovation.

Conclusion

Joachim R. Gruber's contributions to the field of biotechnology, particularly in the areas of wound healing and growth factor research, demonstrate his commitment to advancing medical science. His inventions continue to hold promise for therapeutic applications, and his collaborations underline the importance of teamwork in achieving groundbreaking innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…